Auto-generated from public data. Not the firm's stated position.
Based on disclosed data, Beyond Impact appears to focus on early-stage companies developing alternative protein technologies through precision fermentation and cultivated meat approaches. Recent portfolio suggests concentration in biotech-enabled food innovation across pre-seed through series-b stages, with check sizes ranging from €0.5M to €5.0M.
Generated 10 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.